Skin inflammatory response and efficacy of anti-epidermal growth factor receptor therapy in metastatic colorectal cancer (CUTACETUX).

David Tougeron,Sheik Emambux,Laure Favot,Thierry Lecomte,Ewa Wierzbicka-Hainaut,Mahtab Samimi,Eric Frouin,Nicolas Azzopardi,Jocelyn Chevrier,Laura Serres,Julie Godet,Pierre Levillain,Gilles Paintaud,Aurélie Ferru,Laetitia Rouleau,Adriana Delwail,Christine Silvain,J.-P. Tasu,Franck Morel,Stéphanie Ragot,Jean-Claude Lecron

Skin inflammatory response and efficacy of anti-epidermal growth factor receptor therapy in metastatic colorectal cancer (CUTACETUX).

2020

Anti-epidermal growth factor receptor (EGFR) monoclonal antibody is a standard treatment of metastatic colorectal cancer (mCRC) and its most common adverse effect is a papulopustular acneiform rash...

Keywords:

Growth factor receptor
Cetuximab
Monoclonal antibody
inflammatory response
Papulopustular
Colorectal cancer
Standard treatment
Medicine
Cancer research
Adverse effect

Correction
Source
Cite
Save

References

Citations